Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. [PDF]
Journal of the American Society of Nephrology, 1998 Patients with chronic renal failure often show accumulation of intermediate-density lipoprotein (IDL). Because recent studies have emphasized the atherogenicity of IDL in the general population, we evaluated the relationship between this lipoprotein and aortic atherosclerosis in uremic patients treated with hemodialysis. Aortic pulse wave velocity (PWV)
Takahiro Shoji +7 more
openalex +3 more sources
Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients [PDF]
Kidney International, 1999 It has been reported that remnant lipoproteins and small, dense low-density lipoproteins (LDLs) are risk factors for cardiovascular disease. To determine whether these risk factors are present in hemodialysis (HD) patients who are suffering from a high incidence of atherosclerotic vascular disease, we measured concentrations of remnant lipoproteins and
Keiko Oi +4 more
openalex +4 more sources
Journal of Biological Chemistry, 1986 Upon incubation with rat liver membranes, radioiodinated rat intermediate density lipoproteins (IDL) interacted with at least two binding sites having a low and a high affinity as demonstrated by the curvilinear Scatchard plots obtained from the specific binding data. The purpose of our work was to identify the nature of these binding sites.
Louise Brissette, S P Noël
openalex +4 more sources
Journal of Lipid Research, 1985 The conversion of very low density (VLDL) to low density lipoproteins (LDL) is a two-step process. The first step is mediated by lipoprotein lipase, but the mechanism responsible for the second is obscure.
C J Packard +4 more
doaj +2 more sources
High-Density Lipoprotein Cholesterol and Statin Use Among U.S. Adults With Intermediate 10-Year Predicted ASCVD Risk. [PDF]
JACC AdvZheutlin AR, Jacobs JA, Bress AP.
europepmc +2 more sources
Scandinavian Journal of Clinical and Laboratory Investigation, 1987 A new lecithin:cholesterol acyltransferase (LCAT)-deficient family was found in Japan. In the proband, both LCAT activity and LCAT mass were deficient. The patient's parents, child, and sister, diagnosed as heterozygotes, had half-normal LCAT activity and LCAT mass. In the patient, an increase of intermediate-density lipoprotein (IDL, 1.006 less than d
Shunichi Murano +6 more
openalex +5 more sources
Intermediate-Density Lipoprotein Is a DNA Synthesis Stimulation Factor in Cultured Human Mesangial Cells [PDF]
Nephron, 1996 Yasuhiro Nishida +5 more
openalex +3 more sources
Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood [PDF]
Reviews in Cardiovascular Medicine, 2021 Defined as the total cholesterol minus high-density lipoprotein (HDL), non-HDL cholesterol has been increasingly acknowledged as a measure of risk estimation for developing atherosclerotic cardiovascular diseases (ASCVD).
Saeed Shoar +7 more
doaj +1 more source
Mechanism, clinical consequences, and management of dyslipidemia in children with nephrotic syndrome [PDF]
Childhood Kidney Diseases, 2022 Dyslipidemia in nephrotic syndrome (NS) is often characterized by marked increases in the levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, and other lipoproteins, such as very low-density lipoprotein, intermediate-density ...
Hee Sun Baek
doaj +1 more source
Influence of intermediate-density lipoproteins on the accuracy of the Friedewald formula [PDF]
Clinical Chemistry, 1991 Abstract Values of low-density lipoprotein (LDL) cholesterol (C) according to the Friedewald formula (Clin Chem 1972;18:499-502) were compared with those obtained by lipoprotein fractionation in 98 healthy subjects (control group), 135 specimens from patients with peripheral vascular and cerebrovascular disease (atherosclerotic group ...
Xavier Nogués +3 more
openaire +2 more sources